135 related articles for article (PubMed ID: 3059078)
1. Phospholipid and energy metabolism of cancer cells monitored by 31P magnetic resonance spectroscopy: possible clinical significance.
Cohen JS
Mayo Clin Proc; 1988 Dec; 63(12):1199-207. PubMed ID: 3059078
[TBL] [Abstract][Full Text] [Related]
2. Imaging biochemistry: applications to breast cancer.
Ronen SM; Leach MO
Breast Cancer Res; 2001; 3(1):36-40. PubMed ID: 11250743
[TBL] [Abstract][Full Text] [Related]
3. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
[TBL] [Abstract][Full Text] [Related]
4. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
[TBL] [Abstract][Full Text] [Related]
5. Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.
Wijnen JP; Jiang L; Greenwood TR; Cheng M; Döpkens M; Cao MD; Bhujwalla ZM; Krishnamachary B; Klomp DW; Glunde K
NMR Biomed; 2014 Jun; 27(6):692-9. PubMed ID: 24764256
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of breast cancer cells as revealed by non-invasive magnetic resonance spectroscopy studies.
Kaplan O; Cohen JS
Breast Cancer Res Treat; 1994; 31(2-3):285-99. PubMed ID: 7881106
[TBL] [Abstract][Full Text] [Related]
7. 1H magnetic resonance imaging and 31P magnetic resonance spectroscopy in experimental filariasis.
Shukla-Dave A; Fatma N; Roy R; Srivastava S; Chatterjee RK; Govindaraju V; Viswanathan AK; Raghunathan P
Magn Reson Imaging; 1997; 15(10):1193-8. PubMed ID: 9408140
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy.
Daly PF; Lyon RC; Faustino PJ; Cohen JS
J Biol Chem; 1987 Nov; 262(31):14875-8. PubMed ID: 3667610
[TBL] [Abstract][Full Text] [Related]
9. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells.
Ting YL; Sherr D; Degani H
Anticancer Res; 1996; 16(3B):1381-8. PubMed ID: 8694505
[TBL] [Abstract][Full Text] [Related]
10. Information from combined 1H and 31P NMR studies of cell extracts: differences in metabolism between drug-sensitive and drug-resistant MCF-7 human breast cancer cells.
Kaplan O; van Zijl PC; Cohen JS
Biochem Biophys Res Commun; 1990 Jun; 169(2):383-90. PubMed ID: 2357212
[TBL] [Abstract][Full Text] [Related]
11. Effect of glucose and confluency on phosphorus metabolites of perfused human prostatic adenocarcinoma cells as determined by 31P MRS.
Macdonald JM; Kurhanewicz J; Dahiya R; Espanol MT; Chang LH; Goldberg B; James TL; Narayan P
Magn Reson Med; 1993 Feb; 29(2):244-8. PubMed ID: 8429789
[TBL] [Abstract][Full Text] [Related]
12. 31P magnetic resonance spectroscopy of endothelial cells grown in three-dimensional matrigel construct as an enabling platform technology: I. The effect of glial cells and valproic acid on phosphometabolite levels.
Sterin M; Ringel I; Lecht S; Lelkes PI; Lazarovici P
Endothelium; 2008; 15(5-6):288-98. PubMed ID: 19065320
[TBL] [Abstract][Full Text] [Related]
13. 1H/31P polarization transfer at 9.4 Tesla for improved specificity of detecting phosphomonoesters and phosphodiesters in breast tumor models.
Wijnen JP; Jiang L; Greenwood TR; van der Kemp WJ; Klomp DW; Glunde K
PLoS One; 2014; 9(7):e102256. PubMed ID: 25036036
[TBL] [Abstract][Full Text] [Related]
14. Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro.
Thomas CP; Dixon RM; Tian M; Butler SA; Counsell CJ; Bradley JK; Adams GE; Radda GK
Br J Cancer; 1994 Apr; 69(4):633-40. PubMed ID: 8142251
[TBL] [Abstract][Full Text] [Related]
15. 31P magnetic resonance spectroscopy (MRS) of experimental orbital myositis.
Winguth S; Kurhanewicz J; Wang ML; Quivey JM; James TL; Char DH
Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2417-22. PubMed ID: 2071353
[TBL] [Abstract][Full Text] [Related]
16. Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts.
Kristensen CA; Kristjansen PE; Brünner N; Clarke R; Spang-Thomsen M; Quistorff B
Cancer Res; 1995 Apr; 55(8):1664-9. PubMed ID: 7712472
[TBL] [Abstract][Full Text] [Related]
17. Monitoring tumor growth and regression by 31P magnetic resonance spectroscopy.
Stubbs M; Rodrigues LM; Gusterson BA; Griffiths JR
Adv Enzyme Regul; 1990; 30():217-30. PubMed ID: 2403032
[TBL] [Abstract][Full Text] [Related]
18. Role of oxygen vs. glucose in energy metabolism in a mammary carcinoma perfused ex vivo: direct measurement by 31P NMR.
Eskey CJ; Koretsky AP; Domach MM; Jain RK
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2646-50. PubMed ID: 8464871
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models.
Chung YL; Troy H; Banerji U; Jackson LE; Walton MI; Stubbs M; Griffiths JR; Judson IR; Leach MO; Workman P; Ronen SM
J Natl Cancer Inst; 2003 Nov; 95(21):1624-33. PubMed ID: 14600095
[TBL] [Abstract][Full Text] [Related]
20. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.
Reddy R; Keshavan MS
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):401-5. PubMed ID: 14623493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
